Somatic Systems Valuation
| SMAS Stock | USD 0.0001 0.00 0.000003% |
Somatic Systems seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Somatic Systems from inspecting the company fundamentals such as Revenue of 107.42 K, shares outstanding of 14.6 B, and Profit Margin of (2.23) % as well as reviewing its technical indicators and probability of bankruptcy.
Enterprise Value 1.5 M | Price Sales 13.5898 |
Overvalued
Today
Please note that Somatic Systems' price fluctuation is very steady at this time. Calculation of the real value of Somatic Systems is based on 3 months time horizon. Increasing Somatic Systems' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Somatic stock is determined by what a typical buyer is willing to pay for full or partial control of Somatic Systems. Since Somatic Systems is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Somatic Stock. However, Somatic Systems' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Somatic Systems' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Somatic Systems' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Somatic Systems helps investors to forecast how Somatic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Somatic Systems more accurately as focusing exclusively on Somatic Systems' fundamentals will not take into account other important factors: Somatic Systems Cash |
|
Somatic Systems Total Value Analysis
Somatic Systems is at this time forecasted to have valuation of 1.46 M with market capitalization of 1.46 M, debt of 353.61 K, and cash on hands of 7.67 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Somatic Systems fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.46 M | 1.46 M | 353.61 K | 7.67 K |
Somatic Systems Investor Information
The company had not issued any dividends in recent years. Somatic Systems had 0.05:1 split on the 10th of February 2004. Based on the key indicators related to Somatic Systems' liquidity, profitability, solvency, and operating efficiency, Somatic Systems is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.Somatic Systems Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Somatic implies not a very effective usage of assets in July.Somatic Systems Profitability Analysis
The company reported the previous year's revenue of 107.42 K. Net Loss for the year was (239.08 K) with profit before overhead, payroll, taxes, and interest of 97.66 K.About Somatic Systems Valuation
The stock valuation mechanism determines Somatic Systems' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Somatic Systems based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Somatic Systems. We calculate exposure to Somatic Systems's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Somatic Systems's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 87.9 K | 90.9 K |
Additional Tools for Somatic Stock Analysis
When running Somatic Systems' price analysis, check to measure Somatic Systems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Somatic Systems is operating at the current time. Most of Somatic Systems' value examination focuses on studying past and present price action to predict the probability of Somatic Systems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Somatic Systems' price. Additionally, you may evaluate how the addition of Somatic Systems to your portfolios can decrease your overall portfolio volatility.